九个国家2000-2017年230679例活产儿按胎龄和出生体重精细分层的新生儿死亡风险
该研究基于九個中低收入国家15个基于人群的队列共230679例活产儿,按胎龄和出生体重精细分层分析新生儿死亡风险,发现胎龄和出生体重越低死亡风险越高,<28周早产儿中位新生儿死亡率为359.2/1000活产(RR 18.0),极低出生体重为462.8/1000活产(RR 43.4)。
要点
- <28周早产儿中位新生儿死亡率359.2/1000活产,RR 18.0(95%CI 8.6-37.6)。
- 极低出生体重(<1500 g)新生儿死亡率462.8/1000活产,RR 43.4(95%CI 29.5-63.9)。
- 巨大儿(≥4000 g)新生儿死亡风险无统计学显著差异(RR 1.1,95%CI 0.6-3.0)。
核心结论
- 胎龄和出生体重越低,新生儿死亡风险越高,呈剂量-反应关系。
- 除追踪脆弱新生儿类型外,监测更精细的出生体重和胎龄类别有助于更好理解脆弱新生儿的预测因素、干预措施和健康结局。
- 所有活产和死产新生儿均应准确记录体重和胎龄,以追踪母婴健康并优化脆弱新生儿的预防和照护。
研究设计与样本
- 描述性多国二次数据分析,纳入九个中低收入国家15个基于人群的队列,共230679例活产儿,数据年份为2000至2017年。
- 研究邀请具有高质量出生结局数据的次国家、基于人群的研究加入脆弱新生儿测量协作组(Vulnerable Newborn Measurement Collaboration)。
- 所有研究均包含出生体重、经超声或末次月经测量的胎龄、婴儿性别和新生儿存活情况。
主要发现
- <28周早产儿中位新生儿死亡率359.2/1000活产,RR 18.0(95%CI 8.6-37.6)。
- 极低出生体重(<1500 g)新生儿死亡率462.8/1000活产,RR 43.4(95%CI 29.5-63.9)。
- 巨大儿(≥4000 g)新生儿死亡风险无统计学显著差异(RR 1.1,95%CI 0.6-3.0)。
- 过期产儿(≥42+0周)RR 1.3(95%CI 1.1-1.5),37+0-38+6周儿RR 1.2(95%CI 1.0-1.4)。
- 按地区(撒哈拉以南非洲与南亚)和研究水平新生儿死亡率(≤25/1000活产 vs >25/1000活产)分层,未见统计学显著差异。
关键数值与推荐
- 适出生体重定义为2500-3999 g(参照类别),巨大儿为≥4000 g,中度低出生体重为1500-2499 g,极低出生体重为<1500 g。
- 胎龄精细分层:≥42+0周、39+0-41+6周(参照类别)、37+0-38+6周、34+0-36+6周、32+0-33+6周、30+0-31+6周、28+0-29+6周、<28周。
- 采用Meta分析计算各精细类别的相对死亡风险及95%CI,按地区研究设置(撒哈拉以南非洲与南亚)和研究水平新生儿死亡率(≤25 vs >25/1000活产)分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the mortality risks by fine strata of gestational age and birthweight among 230 679 live births in nine low- and middle-income countries (LMICs) from 2000 to 2017. DESIGN: Descriptive multi-country secondary data analysis. SETTING: Nine LMICs in sub-Saharan Africa, Southern and Eastern Asia, and Latin America. POPULATION: Liveborn infants from 15 population-based cohorts. METHODS: Subnational, population-based studies with high-quality birth outcome data were invited to join the Vulnerable Newborn Measurement Collaboration. All studies included birthweight, gestational age measured by ultrasound or last menstrual period, infant sex and neonatal survival. We defined adequate birthweight as 2500-3999 g (reference category), macrosomia as ≥4000 g, moderate low as 1500-2499 g and very low birthweight as <1500 g. We analysed fine strata classifications of preterm, term and post-term: ≥42+0, 39+0-41+6 (reference category), 37+0-38+6, 34+0-36+6,34+0-36+6,32+0-33+6, 30+0-31+6, 28+0-29+6 and less than 28 weeks. MAIN OUTCOME MEASURES: Median and interquartile ranges by study for neonatal mortality rates (NMR) and relative risks (RR). We also performed meta-analysis for the relative mortality risks with 95% confidence intervals (CIs) by the fine categories, stratified by regional study setting (sub-Saharan Africa and Southern Asia) and study-level NMR (≤25 versus >25 neonatal deaths per 1000 live births). RESULTS: We found a dose-response relationship between lower gestational ages and birthweights with increasing neonatal mortality risks. The highest NMR and RR were among preterm babies born at <28 weeks (median NMR 359.2 per 1000 live births; RR 18.0, 95% CI 8.6-37.6) and very low birthweight (462.8 per 1000 live births; RR 43.4, 95% CI 29.5-63.9). We found no statistically significant neonatal mortality risk for macrosomia (RR 1.1, 95% CI 0.6-3.0) but a statistically significant risk for all preterm babies, post-term babies (RR 1.3, 95% CI 1.1-1.5) and babies born at 370-386 weeks (RR 1.2, 95% CI 1.0-1.4). There were no statistically significant differences by region or underlying neonatal mortality. CONCLUSIONS: In addition to tracking vulnerable newborn types, monitoring finer categories of birthweight and gestational age will allow for better understanding of the predictors, interventions and health outcomes for vulnerable newborns. It is imperative that all newborns from live births and stillbirths have an accurate recorded weight and gestational age to track maternal and neonatal health and optimise prevention and care of vulnerable newborns.
引用
- Hazel EA, Erchick DJ, Katz J, et al. Neonatal mortality risk of vulnerable newborns by fine stratum of gestational age and birthweight for 230 679 live births in nine low- and middle-income countries, 2000-2017. BJOG. 2024. PMID: 38228570. doi:10.1111/1471-0528.17743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。